Quick Answer
bioAffinity Technologies, Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $6.16 million for the year ending 2025.
- bioAffinity Technologies, Inc. showed a decrease of -34.2% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
- This data is from bioAffinity Technologies, Inc.'s annual report (Form 10-K), filed with the SEC on March 16, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 4 years of available data (2022 to 2025), bioAffinity Technologies, Inc.'s Revenue From Contract With Customer Excluding Assessed Tax has grown by 128,194.0%.
- Historical annual values: Fiscal year 2025: $6.16 million | Fiscal year 2024: $9.36 million | Fiscal year 2023: $2.53 million | Fiscal year 2022: $4.8 thousand.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: